You are here

Singapore-based firm on track to commercialise cancer drug

Tessa Therapeutics teams up with California institute to run cancer-therapy trial, commercial launch expected in 2020

Tessa Therapeutics' chief scientific officer John Connolly with his team in the lab Tessa shares with the Institute of Molecular and Cell Biology. Tessa has teamed up with the Parker Institute for Cancer Immunotherapy in California to advance immunotherapy research.


SCIENTISTS are now a step closer to turning cancer patients' own immune cells (T-cells) against the tumours in their bodies - and possibly finding a cure for the dreaded disease.

A Singapore-based biotechnology firm has emerged ahead of the very crowded research field of...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to